Pre- and postconditioning effect of Sevoflurane on myocardial dysfunction after cardiopulmonary resuscitation in rats

被引:32
|
作者
Knapp, Juergen [1 ]
Bergmann, Greta [1 ]
Bruckner, Thomas [2 ]
Russ, Nicolai [1 ]
Boettinger, Bernd W. [3 ]
Popp, Erik [1 ]
机构
[1] Heidelberg Univ, Dept Anaesthesiol, D-69120 Heidelberg, Germany
[2] Heidelberg Univ, Inst Med Biometry & Informat, D-69120 Heidelberg, Germany
[3] Univ Cologne, Dept Anaesthesiol & Postoperat Intens Care Med, D-50937 Cologne, Germany
关键词
Preconditioning; Postconditioning; Cardiac arrest; Volatile anaesthetics; Myocardial dysfunction; Cardiopulmonary resuscitation (CPR);
D O I
10.1016/j.resuscitation.2013.04.012
中图分类号
R4 [临床医学];
学科分类号
1002 ; 100602 ;
摘要
Post-resuscitation myocardial dysfunction is an important cause of death in the intensive care unit after initially successful cardiopulmonary resuscitation (CPR) of pre-hospital cardiac arrest (CA) patients. Volatile anaesthetics reduce ischaemic-reperfusion injury in regional ischaemia in beating hearts. This effect, called anaesthetic-induced pre- or postconditioning, can be shown when the volatile anaesthetic is given either before regional ischaemia or in the reperfusion phase. However, up to now, little data exist for volatile anaesthetics after global ischaemia due to CA. Therefore, the goal of this study was to clarify whether Sevoflurane improves post-resuscitation myocardial dysfunction after CA in rats. Following institutional approval by the Governmental Animal Care Committee, 144 male Wistar rats (341 +/- 19 g) were randomized either to a control group or to one of the 9 interventional groups receiving 0.25 MAC, 0.5 MAC or 1 MAC of Sevoflurane for 5 min either before resuscitation (SBR), during resuscitation (SDR) or after resuscitation (SAR). After 6 min of electrically induced ventricular fibrillation CPR was performed. Before CA (baseline) as well as 1 h and 24h after restoration of spontaneous circulation (ROSC), continuous measurement of ejection fraction (EF), and preload adjusted maximum power (PAMP) as primary outcome parameters and end systolic pressure (ESP), end diastolic volume (EDV) and maximal slope of systolic pressure increment (dP/dt(max)) as secondary outcome parameters was performed using a conductance catheter. EF was improved in all Sevoflurane treated groups 1 h after ROSC in comparison to control, except for the 0.25 MAC SDR and 0.25 MAC SAR group (0.25 MAC SBR: 38 +/- 8,p = 0.02; 0.5 MAC SBR: 39 +/- 7, p = 0.04; 1 MAC SBR: 40 +/- 6, p = 0.007; 0.5 MAC SDR: 38 +/- 7, p = 0.02; 1 MAC SDR: 40 +/- 6, p = 0.006; 0.5 MAC SAR: 39 +/- 6, p = 0.01; 1 MAC SAR: 39 +/- 6, p = 0.002, vs. 30 +/- 7%). Twenty-four hours after ROSC, EF was higher than control in all interventional groups (p<0.05 for all groups). EF recovered to baseline values 24 h after ROSC in all SBR and SAR groups. PAMP was improved in comparison to control (4.6 +/- 3.0 mW/mu l(2)) 24h after ROSC in 0.5 MAC SBR (9.4 +/- 6.9 mW/mu l(2), p = 0.04), 1 MAC SBR (8.9 +/- 4.4 mW/mu l(2), p = 0.04), 1 MAC SDR (8.0 +/- 5.7 mW/mu l(2), p = 0.04), and 1 MAC SAR (7.3 +/- 3.5 mW/mu l(2), p = 0.04). ESP, EDV, and dP/dtmax was not different from control 1 h as well as 24 h after ROSC with the exception of 1 MAC SDR with a reduced ESP 1 h after ROSC (89 +/- 16 vs. 103 +/- 22 mmHg, p =0.04). Sevoflurane treatment did not affect survival rate. This animal study of CA and resuscitation provides the hypothesis that pharmacological pre- or postconditioning with the volatile anaesthetic Sevoflurane - administered before CA, during resuscitation or after ROSC - results in an improved myocardial inotropy 24h after ROSC. Sevoflurane treatment seems to improve EF even in the early phase of reperfusion 1 h after ROSC. Therefore further targeted studies on the optimal dose and time point of administration of Sevoflurane in cardiopulmonary resuscitation seem to be worthwhile (Institutional protocol number: 35-9185.811G-24108). (C) 2013 Elsevier Ireland Ltd. All rights reserved.
引用
收藏
页码:1450 / 1455
页数:6
相关论文
共 50 条
  • [31] Diagnosis of acute myocardial infarction after cardiopulmonary resuscitation
    Müllner, M
    ACTA ANAESTHESIOLOGICA SCANDINAVICA, 1998, 42 : 106 - 108
  • [32] Levosimendan in rats decreases acute kidney injury after cardiopulmonary resuscitation by improving mitochondrial dysfunction
    Zhao, Li
    Tian, Lei
    Wang, Shiwei
    Yang, Weiqiang
    Lu, Xiaoye
    Zhu, Changqing
    TRANSLATIONAL ANDROLOGY AND UROLOGY, 2021, 10 (07) : 3010 - 3020
  • [33] Comparison of cardioprotective and anti-inflammatory effects of ischemia pre- and postconditioning in rats with myocardial ischemia-reperfusion injury
    Xiong, Jun
    Wang, Qiang
    Xue, Fu-Shan
    Yuan, Yuan-Jing
    Li, Shan
    Liu, Jian-Hua
    Liao, Xu
    Zhang, Yan-Ming
    INFLAMMATION RESEARCH, 2011, 60 (06) : 547 - 554
  • [34] SURVIVAL ANALYSIS AFTER CARDIOPULMONARY RESUSCITATION IN RATS WITH MYOCARDIAL INFARCTION TREATED WITH MESENCHYMAL STEM CELLS
    Wang, Tong
    Huang, Zitong
    Tang, Wanchun
    Sun, Shijie
    Xu, Tingyan
    Weil, Max Harry
    Wan, Zhi
    CRITICAL CARE MEDICINE, 2008, 36 (12) : A144 - A144
  • [35] PROGRESSIVE MYOCARDIAL DYSFUNCTION AFTER CARDIAC RESUSCITATION
    TANG, WC
    WEIL, MH
    SUN, SJ
    GAZMURI, RJ
    BISERA, J
    CRITICAL CARE MEDICINE, 1993, 21 (07) : 1046 - 1050
  • [36] Rosuvastatin improves myocardial and neurological outcomes after asphyxial cardiac arrest and cardiopulmonary resuscitation in rats
    Qiu, Yun
    Wu, Yichen
    Meng, Min
    Luo, Man
    Zhao, Hongmei
    Sun, Hong
    Gao, Sumin
    BIOMEDICINE & PHARMACOTHERAPY, 2017, 87 : 503 - 508
  • [37] Effects of sevoflurane postconditioning on the expression of AKT/mTOR and apoptosis of myocardial cells in myocardial ischemia-reperfusion rats
    Liu, F. Q.
    Liu, C. P.
    Xu, M. H.
    Zhu, J.
    Yu, W.
    Wang, L. L.
    JOURNAL OF BIOLOGICAL REGULATORS AND HOMEOSTATIC AGENTS, 2020, 34 (05): : 1909 - 1913
  • [38] The effect of global hypoxia on myocardial function after successful cardiopulmonary resuscitation in a laboratory model
    McCaul, CL
    McNamara, P
    Engelberts, D
    Slorach, C
    Hornberger, LK
    Kavanagh, BP
    RESUSCITATION, 2006, 68 (02) : 267 - 275
  • [39] Cyclosporin a does not prevent myocardial dysfunction after resuscitation from cardiac arrest in rats
    Ayoub, Iyad M.
    Radhakrishnan, Jeejabai
    Gazmuri, Raul J.
    CIRCULATION, 2007, 116 (16) : 941 - 942
  • [40] The autophagy in neuron injury after cardiopulmonary resuscitation in rats
    Hu, ChunLin
    Dai, Xuan
    Liao, Xiaoxing
    Wei, Hongyan
    Li, Xin
    Dai, Gang
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2015, 66 (16) : C270 - C270